Guillermo Mazzolini

8PUBLICATIONS
6CO-AUTHORS
Haematological tumoursCancer cell biologyCancer diagnosisPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 23, 2025
Epigenetic therapies in hepatocellular carcinoma: emerging clinical tools and applications.

Barbara Bueloni, Maite G Fernandez-Barrena, Esteban Fiore

|May 28, 2025
Epigenetic mechanisms involved in hepatocellular carcinoma development and progression.

Barbara Bueloni, Maite Garcia Fernandez de Barrena, Matias Antonio Avila

|Aug 26, 2022
The role of SPARC (secreted protein acidic and rich in cysteine) in the pathogenesis of obesity, type 2 diabetes, and non-alcoholic fatty liver disease.

Catalina Atorrasagasti, Agostina M Onorato, Guillermo Mazzolini

|Jul 05, 2022
Prevention of hepatocellular carcinoma and monitoring of high-risk patients.

Eda Kaya, Guillermo Daniel Mazzolini, Yusuf Yilmaz

|Feb 28, 2021
SPARC inhibition accelerates NAFLD-associated hepatocellular carcinoma development by dysregulating hepatic lipid metabolism.

Agostina M Onorato, Esteban Fiore, Juan Bayo

Pageof 2